TRPM3 and cyst: In E12.5 kidneys treated with the TRPM3 inhibitor, isosakuranetin, along with a range of IBMX concentrations, cyst formation was observed at all tested IBMX concentrations from 0.5 to 50 μM (Fig. S8a–f).